Anna Morabito

1.5k total citations
37 papers, 992 citations indexed

About

Anna Morabito is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Morabito has authored 37 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 14 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Morabito's work include T-cell and B-cell Immunology (16 papers), Immunotherapy and Immune Responses (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Anna Morabito is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Immunotherapy and Immune Responses (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Anna Morabito collaborates with scholars based in Italy, United Kingdom and United States. Anna Morabito's co-authors include Maria Pia Pistillo, Barbara Banelli, Massimo Romani, Stefania Laurent, Vincenzo Fontana, Patrizia Piccioli, Alessandra Forlani, Giorgio Allemanni, Béatrice Dozin and Sandra Salvi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Anna Morabito

35 papers receiving 985 citations

Peers

Countries citing papers authored by Anna Morabito

Since Specialization

Citations

This map shows the geographic impact of Anna Morabito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Morabito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Morabito more than expected).

Fields of papers citing papers by Anna Morabito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Morabito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Morabito. The network helps show where Anna Morabito may publish in the future.

Co-authorship network of co-authors of Anna Morabito

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Morabito. A scholar is included among the top collaborators of Anna Morabito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Morabito. Anna Morabito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine Learning Methods for Gene Selection in Uveal Melanoma 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Max J. Pfeffer, Anna Morabito, Enrica T. Tanda, Francesco Spagnolo, Michela Croce, Ulrich Pfeffer, Adriana Amaro	0
2	Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma 2024 ·Archives of Dermatological Research ·Andrea Boutros, Roberta Carosio, (unknown), Barbara Banelli, Anna Morabito, Maria Pia Pistillo, (unknown), Paola Queirolo, Enrica T. Tanda, Edoardo Raposio, Vincenzo Fontana, Francesco Spagnolo	0
3	The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors 2023 ·Immuno-Oncology Technology ·Andrea Boutros, Roberta Carosio, (unknown), Francesco Spagnolo, Barbara Banelli, Anna Morabito, Maria Pia Pistillo, (unknown), Franco Cecchi, P. Pronzato, Paola Queirolo, Edoardo Raposio, V. Fontana, Enrica T. Tanda	3
4	Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization 2020 ·Cancer Immunology Immunotherapy ·Luca Mastracci, Vincenzo Fontana, Paola Queirolo, Roberta Carosio, Federica Grillo, Anna Morabito, Barbara Banelli, Enrica T. Tanda, Andrea Boutros, Béatrice Dozin, Marina Gualco, Sandra Salvi, Massimo Romani, Francesco Spagnolo, Alessandro Poggi, Maria Pia Pistillo	16
5	Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab 2020 ·Clinical Immunology ·Maria Pia Pistillo, Roberta Carosio, Federica Grillo, Vincenzo Fontana, Luca Mastracci, Anna Morabito, Barbara Banelli, Enrica T. Tanda, (unknown), Béatrice Dozin, Marina Gualco, Sandra Salvi, Francesco Spagnolo, Alessandro Poggi, Paola Queirolo	22
6	Immune Checkpoints and Innovative Therapies in Glioblastoma 2018 ·Frontiers in Oncology ·Massimo Romani, Maria Pia Pistillo, Roberta Carosio, Anna Morabito, Barbara Banelli	68
7	Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma 2017 ·Anticancer Research ·(unknown), Pier Aldo Canessa, Paola Ferro, (unknown), Vincenzo Fontana, (unknown), Valentina Pinelli, Anna Morabito, Franco Fedeli, Maria Pia Pistillo, Silvio Roncella	17
8	Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 2015 ·Journal of Translational Medicine ·Silvia Boero, Anna Morabito, Barbara Banelli, Bárbara Cardinali, Béatrice Dozin, Gianluigi Lunardi, Patrizia Piccioli, Sonia Lastraioli, Roberta Carosio, Sandra Salvi, Alessia Levaggi, Francesca Poggio, Alessia D’Alonzo, Massimo Romani, Lucia Del Mastro, Alessandro Poggi, Maria Pia Pistillo	35
9	A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: Potential applications in autoimmunity and cancer 2014 ·Human Immunology ·Barbara Banelli, Anna Morabito, Stefania Laurent, Patrizia Piccioli, Béatrice Dozin, Massimo Ghio, Paolo A. Ascierto, Stefano Monteghirfo, (unknown), (unknown), Paola Queirolo, Massimo Romani, Maria Pia Pistillo	6
10	Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study 2013 ·Cancer Investigation ·Paola Queirolo, Anna Morabito, Stefania Laurent, Sonia Lastraioli, Patrizia Piccioli, Paolo A. Ascierto, Giusy Gentilcore, Martina Serra, (unknown), Elena Tornari, Béatrice Dozin, Maria Pia Pistillo	44
11	The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production 2013 ·Journal of Translational Medicine ·Stefania Laurent, Paola Queirolo, Silvia Boero, Sandra Salvi, Patrizia Piccioli, Simona Boccardo, Simona Minghelli, Anna Morabito, Vincenzo Fontana, Gabriella Pietra, Paolo Carrega, Nicoletta Ferrari, Francesca Tosetti, Lung-Ji Chang, Maria Cristina Mingari, Guido Ferlazzo, Alessandro Poggi, Maria Pia Pistillo	129
12	Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer 2012 ·Cancer Immunology Immunotherapy ·Sandra Salvi, Vincenzo Fontana, Simona Boccardo, Domenico Franco Merlo, (unknown), Stefania Laurent, Anna Morabito, Erika Rijavec, Maria Giovanna Dal Bello, Marco Mora, Giovanni Battista Ratto, Francesco Grossi, Mauro Truini, Maria Pia Pistillo	111
13	CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions 2010 ·Human Immunology ·Stefania Laurent, Paolo Carrega, Danièle Saverino, Patrizia Piccioli, Marta Camoriano, Anna Morabito, Béatrice Dozin, Vincenzo Fontana, Rita Simone, Lorenzo Mortara, Maria Cristina Mingari, Guido Ferlazzo, Maria Pia Pistillo	95
14	Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and β2-microglobulin downregulation in breast cancer 2009 ·Human Immunology ·Anna Morabito, Béatrice Dozin, Sandra Salvi, (unknown), (unknown), Stefania Laurent, Simona Pastorino, Franca Carli, Mauro Truini, Paolo Bruzzi, Lucia Del Mastro, Maria Pia Pistillo	6
15	CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence 2009 ·Annals of Hematology ·Patrizia Piccioli, (unknown), Martina Serra, Anna Morabito, Teresa Lamparelli, Marco Gobbi, Stefania Laurent, Béatrice Dozin, Paolo Bruzzi, Anna Maria Ferraris, Andrea Bacigalupo, Rosario Notaro, Maria Pia Pistillo	16
16	CTLA‐4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis 2007 ·British Journal of Haematology ·Stefania Laurent, Giulio Lelio Palmisano, Alberto M. Martelli, Tomohiro Kato, Pier Luigi Tazzari, Ivana Pierri, Marino Clavio, Béatrice Dozin, (unknown), (unknown), Anna Morabito, Teresa Lamparelli, Andrea Bacigalupo, Marco Gobbi, Maria Pia Pistillo	37
17	HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines 2004 ·Human Immunology ·Giulio Lelio Palmisano, (unknown), Anna Morabito, (unknown), Giovanni Battista Ferrara, Maria Pia Pistillo	43
18	HLA‐C sequence based typing: nucleotide analysis from exon 1 through exon 8. Identification of a new allele: Cw0718 2003 ·Tissue Antigens* ·Laura Delfino, Anna Morabito, G. B. Ferrara	15
19	HLA‐A typing: comparison between serology, the amplification refractory mutation system with polymerasee chain reaction and sequencing 1997 ·Tissue Antigens ·(unknown), (unknown), Anna Morabito, Anna Longo, L Johnston-Dow, (unknown), Marco Colonna, G. B. Ferrara	26
20	First-line systemic therapy for metastatic breast cancer and management of pleural effusion 1995 ·Annals of Oncology ·Federica Perrone, Chiara Carlomagno, Sabino De Placido, Rossella Lauria, Anna Morabito, Aida Bianco	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact